{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:52:45Z","timestamp":1780595565047,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T00:00:00Z","timestamp":1488844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Revalesio Corporation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s11064-017-2214-z","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T07:16:53Z","timestamp":1488871013000},"page":"1555-1570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy"],"prefix":"10.1007","volume":"42","author":[{"given":"Susanta","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh B.","family":"Rangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supurna","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"key":"2214_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrneurol.2016.59","volume":"12","author":"M Absinta","year":"2016","unstructured":"Absinta M, Sati P, Reich DS (2016) Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol 12:358\u2013368","journal-title":"Nat Rev Neurol"},{"key":"2214_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nri2190","volume":"7","author":"AG Baxter","year":"2007","unstructured":"Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904\u2013912","journal-title":"Nat Rev Immunol"},{"key":"2214_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","volume":"11","author":"G Mandolesi","year":"2015","unstructured":"Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, Sepman H, Marfia GA, Centonze D (2015) Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat Rev Neurol 11:711\u2013724","journal-title":"Nat Rev Neurol"},{"key":"2214_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0065-2776(08)60273-4","volume":"5","author":"PY Paterson","year":"1966","unstructured":"Paterson PY (1966) Experimental allergic encephalomyelitis and autoimmune disease. Adv Immunol 5:131\u2013208","journal-title":"Adv Immunol"},{"key":"2214_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11481-010-9219-6","volume":"5","author":"K Pahan","year":"2010","unstructured":"Pahan K (2010) Neuroimmune pharmacological control of EAE. J Neuroimmune Pharmacol 5:165\u2013167","journal-title":"J Neuroimmune Pharmacol"},{"key":"2214_CR6","doi-asserted-by":"publisher","first-page":"e51869","DOI":"10.1371\/journal.pone.0051869","volume":"7","author":"S Mondal","year":"2012","unstructured":"Mondal S, Martinson JA, Ghosh S, Watson R, Pahan K (2012) Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline. PLoS ONE 7:e51869","journal-title":"PLoS ONE"},{"key":"2214_CR7","doi-asserted-by":"publisher","first-page":"29529","DOI":"10.1074\/jbc.M111.338012","volume":"287","author":"S Khasnavis","year":"2012","unstructured":"Khasnavis S, Jana A, Roy A, Mazumder M, Bhushan B, Wood T, Ghosh S, Watson R, Pahan K (2012) Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J Biol Chem 287:29529\u201329542","journal-title":"J Biol Chem"},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"e12261","DOI":"10.14814\/phy2.12261","volume":"3","author":"S Choi","year":"2015","unstructured":"Choi S, Yu E, Kim DS, Sugimori M, Llinas RR (2015) RNS60, a charge-stabilized nanostructure saline alters Xenopus Laevis oocyte biophysical membrane properties by enhancing mitochondrial ATP production. Physiol Rep 3:e12261","journal-title":"Physiol Rep"},{"key":"2214_CR9","doi-asserted-by":"publisher","first-page":"e0116566","DOI":"10.1371\/journal.pone.0116566","volume":"10","author":"S Mondal","year":"2015","unstructured":"Mondal S, Pahan K (2015) Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. PLoS ONE 10:e0116566","journal-title":"PLoS ONE"},{"key":"2214_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.4049\/jimmunol.173.2.1344","volume":"173","author":"S Dasgupta","year":"2004","unstructured":"Dasgupta S, Jana M, Zhou Y, Fung YK, Ghosh S, Pahan K (2004) Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J Immunol 173:1344\u20131354","journal-title":"J Immunol"},{"key":"2214_CR11","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.4049\/jimmunol.170.7.3874","volume":"170","author":"S Dasgupta","year":"2003","unstructured":"Dasgupta S, Zhou Y, Jana M, Banik NL, Pahan K (2003) Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL\/J mice at multiple steps. J Immunol 170:3874\u20133882","journal-title":"J Immunol"},{"key":"2214_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4049\/jimmunol.179.1.275","volume":"179","author":"S Brahmachari","year":"2007","unstructured":"Brahmachari S, Pahan K (2007) Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis. J Immunol 179:275\u2013283","journal-title":"J Immunol"},{"key":"2214_CR13","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.4049\/jimmunol.0801734","volume":"182","author":"S Mondal","year":"2009","unstructured":"Mondal S, Roy A, Pahan K (2009) Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis. J Immunol 182:5013\u20135023","journal-title":"J Immunol"},{"key":"2214_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11481-013-9447-7","volume":"8","author":"A Jana","year":"2013","unstructured":"Jana A, Modi KK, Roy A, Anderson JA, van Breemen RB, Pahan K (2013) Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders. J Neuroimmune Pharmacol 8:739\u2013755","journal-title":"J Neuroimmune Pharmacol"},{"key":"2214_CR15","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.1501628","volume":"197","author":"M Kundu","year":"2016","unstructured":"Kundu M, Mondal S, Roy A, Martinson JL, Pahan K (2016) Sodium benzoate, a food additive and a metabolite of cinnamon, enriches regulatory t cells via stat6-mediated upregulation of TGF-beta. J Immunol 197:3099\u20133110","journal-title":"J Immunol"},{"key":"2214_CR16","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4049\/jimmunol.0800276","volume":"183","author":"S Brahmachari","year":"2009","unstructured":"Brahmachari S, Pahan K (2009) Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183:2045\u20132058","journal-title":"J Immunol"},{"key":"2214_CR17","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.0804394","volume":"184","author":"S Brahmachari","year":"2010","unstructured":"Brahmachari S, Pahan K (2010) Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide. J Immunol 184:1799\u20131809","journal-title":"J Immunol"},{"key":"2214_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0167-5699(89)90236-3","volume":"10","author":"DA Hafler","year":"1989","unstructured":"Hafler DA, Weiner HL (1989) MS: a CNS and systemic autoimmune disease. Immunol Today 10:104\u2013107","journal-title":"Immunol Today"},{"key":"2214_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","volume":"85","author":"L Steinman","year":"1996","unstructured":"Steinman L (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299\u2013302","journal-title":"Cell"},{"key":"2214_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1126\/science.6217550","volume":"219","author":"U Traugott","year":"1983","unstructured":"Traugott U, Reinherz EL, Raine CS (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308\u2013310","journal-title":"Science"},{"key":"2214_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345\u2013352","journal-title":"Nat Immunol"},{"key":"2214_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1126\/science.1142331","volume":"317","author":"S Sakaguchi","year":"2007","unstructured":"Sakaguchi S, Powrie F (2007) Emerging challenges in regulatory T cell function and biology. Science 317:627\u2013629","journal-title":"Science"},{"key":"2214_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11481-009-9188-9","volume":"5","author":"M El-behi","year":"2010","unstructured":"El-behi M, Rostami A, Ciric B (2010) Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 5:189\u2013197","journal-title":"J Neuroimmune Pharmacol"},{"key":"2214_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY (2009) CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986\u2013991","journal-title":"Science"},{"key":"2214_CR25","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.4049\/jimmunol.181.10.7205","volume":"181","author":"G Shi","year":"2008","unstructured":"Shi G, Cox CA, Vistica BP, Tan C, Wawrousek EF, Gery I (2008) Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J Immunol 181:7205\u20137213","journal-title":"J Immunol"},{"key":"2214_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(12)70059-5","volume":"11","author":"JA Cohen","year":"2012","unstructured":"Cohen JA, Reingold SC, Polman CH, Wolinsky JS (2012) Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol 11:467\u2013476","journal-title":"Lancet Neurol"},{"key":"2214_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00007611-199704000-00001","volume":"90","author":"A Miller","year":"1997","unstructured":"Miller A (1997) Current and investigational therapies used to alter the course of disease in multiple sclerosis. South Med J 90:367\u2013375","journal-title":"South Med J"},{"key":"2214_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13365-016-0449-0","volume":"22","author":"MH Werner","year":"2016","unstructured":"Werner MH, Huang D (2016) Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus. J Neurovirol 22:871\u2013875","journal-title":"J Neurovirol"},{"key":"2214_CR29","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/WNL.0000000000002654","volume":"86","author":"TV Gyang","year":"2016","unstructured":"Gyang TV, Hamel J, Goodman AD, Gross RA, Samkoff L (2016) Fingolimod-associated PML in a patient with prior immunosuppression. Neurology 86:1843\u20131845","journal-title":"Neurology"},{"key":"2214_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","volume":"123","author":"K Venken","year":"2008","unstructured":"Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens JL, Medaer R, Hupperts R, Stinissen P (2008) Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123:79\u201389","journal-title":"Immunology"},{"key":"2214_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.0105-2896.2005.00247.x","volume":"204","author":"S Paust","year":"2005","unstructured":"Paust S, Cantor H (2005) Regulatory T cells and autoimmune disease. Immunol Rev 204:195\u2013207","journal-title":"Immunol Rev"},{"key":"2214_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"SF Ziegler","year":"2006","unstructured":"Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24:209\u2013226","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2214_CR33","first-page":"29923007","volume":"197","author":"D Wang","year":"2015","unstructured":"Wang D, Ghosh D, Islam SM, Moorman CD, Thomason AE, Wilkinson DS, Mannie MD (2015) IFN-beta facilitates neuroantigen-dependent induction of CD25+ FOXP3+ regulatory T cells that suppress experimental autoimmune encephalomyelitis. J Immunol 197(8):2992\u20133007","journal-title":"J Immunol"},{"key":"2214_CR34","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","volume":"37","author":"W Niedbala","year":"2007","unstructured":"Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37:3021\u20133029","journal-title":"Eur J Immunol"},{"key":"2214_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nri1488","volume":"4","author":"PJ Coffer","year":"2004","unstructured":"Coffer PJ, Burgering BM (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4:889\u2013899","journal-title":"Nat Rev Immunol"},{"key":"2214_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4049\/jimmunol.170.1.394","volume":"170","author":"D Xu","year":"2003","unstructured":"Xu D, Liu H, Komai-Koma M, Campbell C, McSharry C, Alexander J, Liew FY (2003) CD4+ CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 170:394\u2013399","journal-title":"J Immunol"}],"updated-by":[{"DOI":"10.1007\/s11064-018-2506-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000}}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-017-2214-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T04:42:23Z","timestamp":1492663343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-017-2214-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1007\/s11064-017-2214-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11064-018-2506-y","asserted-by":"object"}]},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}